Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at its General Oral Solid Formulation Facility (F-I) at Panelav during the period from March 9, 2020 to March 13, 2020.
With this, EIR is in place for all the company’s manufacturing facilities for international markets.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
